These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
708 related articles for article (PubMed ID: 14605601)
1. Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience. Giusti M; Zoccola R; Guazzini B; Molinari E; Valenti S; Villa G; Bertolazzi L; Minuto F Minerva Endocrinol; 2003 Sep; 28(3):191-203. PubMed ID: 14605601 [TBL] [Abstract][Full Text] [Related]
2. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin? Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617 [TBL] [Abstract][Full Text] [Related]
3. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer. Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328 [TBL] [Abstract][Full Text] [Related]
4. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy. Lind P; Gallowitsch HJ Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519 [TBL] [Abstract][Full Text] [Related]
5. Nuclear medicine approaches in the monitoring of thyroid cancer patients. Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A J BUON; 2006; 11(4):511-8. PubMed ID: 17309186 [TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. Torlontano M; Crocetti U; Augello G; D'Aloiso L; Bonfitto N; Varraso A; Dicembrino F; Modoni S; Frusciante V; Di Giorgio A; Bruno R; Filetti S; Trischitta V J Clin Endocrinol Metab; 2006 Jan; 91(1):60-3. PubMed ID: 16219716 [TBL] [Abstract][Full Text] [Related]
7. [Assessment of recombinant human thyrotropin application in following-up patients with well-differentiated thyroid carcinoma]. Rajkovaca Z; Kovacević P; Stanetić M; Ristić S Vojnosanit Pregl; 2012 Nov; 69(11):941-6. PubMed ID: 23311243 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. Pacini F; Molinaro E; Castagna MG; Agate L; Elisei R; Ceccarelli C; Lippi F; Taddei D; Grasso L; Pinchera A J Clin Endocrinol Metab; 2003 Aug; 88(8):3668-73. PubMed ID: 12915653 [TBL] [Abstract][Full Text] [Related]
9. The use of recombinant human TSH in the follow-up of differentiated thyroid cancer: experience from a large patient cohort in a single centre. Giovanni V; Arianna LG; Antonio C; Francesco F; Michele K; Giovanni S; Marco S; Giovanni L Clin Endocrinol (Oxf); 2002 Feb; 56(2):247-52. PubMed ID: 11874417 [TBL] [Abstract][Full Text] [Related]
10. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation. Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272 [TBL] [Abstract][Full Text] [Related]
11. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma. David A; Blotta A; Rossi R; Zatelli MC; Bondanelli M; Roti E; Braverman LE; Busutti L; degli Uberti EC Thyroid; 2005 Feb; 15(2):158-64. PubMed ID: 15753676 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer. Podoba J Bratisl Lek Listy; 2010; 111(1):38-40. PubMed ID: 20429310 [TBL] [Abstract][Full Text] [Related]
13. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. Torlontano M; Attard M; Crocetti U; Tumino S; Bruno R; Costante G; D'Azzò G; Meringolo D; Ferretti E; Sacco R; Arturi F; Filetti S J Clin Endocrinol Metab; 2004 Jul; 89(7):3402-7. PubMed ID: 15240622 [TBL] [Abstract][Full Text] [Related]
14. Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. Torlontano M; Crocetti U; D'Aloiso L; Bonfitto N; Di Giorgio A; Modoni S; Valle G; Frusciante V; Bisceglia M; Filetti S; Schlumberger M; Trischitta V Eur J Endocrinol; 2003 Jan; 148(1):19-24. PubMed ID: 12534353 [TBL] [Abstract][Full Text] [Related]
15. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels. Pellegriti G; Scollo C; Regalbuto C; Attard M; Marozzi P; Vermiglio F; Violi MA; Cianci M; Vigneri R; Pezzino V; Squatrito S Clin Endocrinol (Oxf); 2003 May; 58(5):556-61. PubMed ID: 12699436 [TBL] [Abstract][Full Text] [Related]
16. Tc-99m MIBI SPECT in detecting metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan. Hsu CH; Liu FY; Yen RF; Kao CH Endocr Res; 2003 Feb; 29(1):9-15. PubMed ID: 12665314 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of administration of rhTSH with withdrawal of thyroid hormone. Follow-up of patients with differentiated thyroid carcinoma]. Caresia AP; Castell Conesa J; Obiols Alfonso G; Pifarré Montaner P; Negre Busó M; García Alonso C; Galofré Mora P; Mesa Manteca J Rev Esp Med Nucl; 2006; 25(4):236-41. PubMed ID: 16827986 [TBL] [Abstract][Full Text] [Related]
18. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures. Giovanella L; Ceriani L; Ghelfo A; Keller F; Sacchi A; Maffioli M; Spriano G Clin Chem Lab Med; 2006; 44(5):648-52. PubMed ID: 16681439 [TBL] [Abstract][Full Text] [Related]